Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
AMOXICILINA/ACIDO CLAVULANICO CINFA 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG
Suspension
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- AMOXICILINA — 875 mg
- CLAVULANICO ACIDO — 125 mg
- Pharmaceutical form Home Med Cabinet grouping
- Suspension
- Availability in Spain
- All 2 packs marketed
Packs
AMOXICILINA/ACIDO CLAVULANICO CINFA 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 20 sobres
20 pcs
National code
Marketed694756Strength of this pack 875 mg
AMOXICILINA/ACIDO CLAVULANICO CINFA 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 30 sobres
30 pcs
National code
Marketed694757Strength of this pack 875 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 66567Official data
- Marketing authorisation holder
- LABORATORIOS CINFA S.A.Official data
- Authorised
- Feb 1, 2005Official data
- Authority form code
- 9Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.